Shkreli, the pharmaceutical executive known as 'Pharma Bro,' for defrauding investors in his hedge funds and conspiring to manipulate the stock of Retrophin Inc, a biotechnology company he ran." The judges "rejected Shkreli's argument that his trial judge gave incorrect and confusing instruction about securi